Fen-Phen and Redux Heart Valve Problems
At Phillips Law Group in Phoenix, our lawyers understand how scary the side effects of drugs can be. Fen-phen and Redux were prescribed to help overweight individuals lose weight. Unfortunately, many suffered serious consequences, including heart valve damage, primary pulmonary hypertension, and secondary pulmonary hypertension.
If you or a loved one has taken fen-phen or Redux and have suffered from cardiovascular problems, please contact our attorneys at the Phoenix law firm of Phillips Law Group. We can help you evaluate your situation and determine whether or not you have a viable defective drug claim.
Primary pulmonary hypertension (PPH) is a rare disease of unknown cause that results in the progressive narrowing of the blood vessels of the lungs, causing high blood pressure in these blood vessels and eventually leading to heart failure. Secondary pulmonary hypertension (SPH) is the result of other types of lung disease, abnormal breathing processes or heart disease.
Use of certain fenfluramine and dexfenfluramine drugs (fen-phen) and the anti-obesity drug Redux have been found to increase the risk of developing PPH, especially with use lasting more than three months. Initial symptoms of PPH may be very minor, and diagnosis may be delayed for several years until symptoms worsen. Typical symptoms may include:
- Shortness of breath following exertion
- Excessive fatigue
- Dizziness, fainting, and weakness
- Ankle swelling
- Bluish lips and skin
- Chest pain
If you have taken either fen-phen or Redux for more than three months and have any shortness of breath, chest pain or unusual fatigue, the Federal Drug Administration and the American Board of Cardiology recommend that you have an echocardiogram. It might also be wise to consult our experienced attorneys in Phoenix and surrounding areas of Arizona at Phillips Law Group. Contact us.